Daiichi Sankyo Co Ltd Ord (DSKYF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for waiting. We are going to start Daichi Sankyo's FI2025 financial results announcement and FI2026 FI2035 year business plan presentation and discussion. I'm delighted to serve as MC today. I'm Ari Fujishiro from the investor relations and shareholder relations department. First about the language. In this briefing session, you're going to use Japanese and English. simultaneous translation is available. Please click the interpretation icon at the bottom of your Zoom screen and choose Japanese, English or the original audio. If you choose the original audio, you can listen to the original sound. On Zoom screen and during live streaming, we will show a presentation material in Japanese. We have posted a presentation in both Japanese and English on our corporate website and the IR library Financial Results Presentation Material or IR Presentation Material section. Please download the files if necessary. Today, five members are in attendance. Representative Director, President and CEO, Hiroyuki Okuzawa, Senior Executive Officer, CFO, Tomohiro Kodama, Director, Head of Oncology Business Unit, Ken Keda, Head of Global R&D, John Tsai, and Senior Executive Officer, Head of R&D Division, Yuki Abe. Today, after FY2025 financial results announcement, we will present FY2026 to FY2030 five-year business plan. At the end, we will have time for Q&A with all the executives. We will entertain questions from investors and analysts until 8 p.m. We will take questions from members of the media from Ten minutes past eight. Please note that this meeting is being recorded. Thank you for your understanding. We are starting FI 2025 financial results announcement. Okuzawa-san, please. Okuzawa speaking. Thank you very much for joining Daiichi Sankyo's FI 2025 financial results annou...